ARCHIVES

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014

NTP Panel Completed To Write New Testing, Evolution Guidelines

April 22, 1983

Copeland Named Director, UF Cancer Center

February 10, 1995

Targeting Men At High Risk Finds More Head & Neck Cancer

September 24, 2010

Groups Have No Budgets As NCTN Begins Work March 1

February 28, 2014

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991